Psychedelics have gained renewed attention in scientific communities for their potential therapeutic applications. Compounds such as psilocybin, LSD, and DMT are now being studied not just for their psychoactive properties but for their impact on neuroplasticity, depression, PTSD, and addiction treatment. Research institutions and mental health professionals alike are beginning to see these substances not as threats, but as tools—when used responsibly under controlled conditions. El Jardín Químico supports this growing movement by offering high-purity psychedelics strictly for research and analytical purposes. This blog explores how regulatory shifts and scientific validation are ushering in a new era for psychedelics in neuroscience and mental health research.